title: p21WAF1 and p53 immunohistochemical expression in breast carcinoma may predict therapeutic response to adjuvant treatment.
authors.forename: M
authors.initials: M
authors.lastname: Barbareschi
authors.forename: C
authors.initials: C
authors.lastname: Doglioni
authors.forename: S
authors.initials: S
authors.lastname: Veronese
authors.forename: M
authors.initials: M
authors.lastname: Bonzanini
authors.forename: P
authors.initials: P
authors.lastname: Dalla Palma
authors.forename: A L
authors.initials: AL
authors.lastname: Harris
authors.forename: O
authors.initials: O
authors.lastname: Caffo
mesh_terms: D014408:Biomarkers, Tumor / Q000378:metabolism*; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D050759:Cyclin-Dependent Kinase Inhibitor p21; D016213:Cyclins / Q000378:metabolism*; D005260:Female; D006801:Humans; D009363:Neoplasm Proteins / Q000378:metabolism; D015996:Survival Rate; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*
chemical_list: D014408:Biomarkers, Tumor; C493956:CDKN1A protein, human; D050759:Cyclin-Dependent Kinase Inhibitor p21; D016213:Cyclins; D009363:Neoplasm Proteins; D016159:Tumor Suppressor Protein p53